BMS-247550
Term · Oncology and biomedicine · MLC-T-ONC-001146
A drug used alone or with capecitabine to treat breast cancer that is locally advanced or has spread to other parts of the body and did not get better after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. BMS-247550 blocks cell growth by stopping cell division and may kill cancer cells. It is a type of epothilone analog and a type of antimicrotubule agent. Also called ixabepilone and Ixempra.
| Identifier | MLC-T-ONC-001146 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | ixabepilone; Ixempra |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001146",
"term": "BMS-247550",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with capecitabine to treat breast cancer that is locally advanced or has spread to other parts of the body and did not get better after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. BMS-247550 blocks cell growth by stopping cell division and may kill cancer cells. It is a type of epothilone analog and a type of antimicrotubule agent. Also called ixabepilone and Ixempra.",
"expansions": [
"ixabepilone",
"Ixempra"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bms-247550/"
}
Record 3,697 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.